FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

12778311000001107: Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
44995501000001118 Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100990401000001115 Octreotide 500micrograms/1ml solution for injection vials (Pfizer Ltd) 5 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Is a Octreotide 500micrograms/1ml solution for injection vials 5 vial true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Is pack of Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) false Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has active ingredient Octreotide acetate false Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has AMP Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has basis of strength substance Octreotide true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start